In the mid-1980s, elegant studies on mouse embryos revealed thatboth parentalgenomes are required for normal development leading to the discovery of genomic imprinting. Imprinting is a parent-of-origin-dependent epigenetic mechanism whereby a subset of autosomal genes is expressed from only one of the parental alleles. Imprinting control involves both DNA-and histone-methylation, which differentially mark the parental alleles. More than a hundred imprinted genes have been identified so far, many of which play important roles in the regulation of growth and development. Nonetheless, the full extent of imprinting and its biological functions remain underestimated. In this review, we describe recently developed strategies to identify novel imprinted genes and highlight the potential of combining several high throughput approaches. By integrating databases obtained from epigenome-and transcriptome-wide analyses, we now have the unique opportunity to identify all the imprinted genes in the human/mouse genomes.
INTRODUCTION
In the mid-1980s, embryological studies in the mouse demonstrated the functional non-equivalence of the maternal and paternal genomes. Specifically, conceptuses derived from zygotes that contained two sets of the maternal chromosomes (called gynogenotes) or two sets of the paternal chromosomes (called androgenotes) failed to develop beyond midgestation [1, 2] . These findings established that diploidy alone was not sufficient to sustain embryonic development and suggested the existence of genes that were expressed only on the allele inherited from the mother or the father. These genes were called 'imprinted genes'. In the following years this assumption was confirmed through the characterization of insulin-like growth factor 2 (Igf2) as a paternally-expressed and of H19 and Igf2r (IGF2receptor) as maternally-expressed genes in the mouse [3] [4] [5] .
Since then, more than hundred imprinted genes have been identified in the mouse and about half of them are expressed from the maternal allele and the other half from the paternal allele (an up-to-date list is available at http://www.har.mrc.ac.uk/ research/genomic_imprinting/). Although for the majority of them the imprinting status is conserved also in their human orthologues, some failed to show imprinted expression in humans [6, 7] . More rarely, some are imprinted in the human only (see http://igc.otago.ac.nz/home.html for details). Nevertheless, the number of identified imprinted genes is unlikely to be complete as the precise extent of imprinting in the mouse or human genome is not fully known. Estimates of their actual total number range from 100 to 2100 [7] [8] [9] .
As suggested by the developmental failure of uniparental conceptuses [1, 2] , many of these genes are involved in regulation of cell proliferation and growth in both placenta and embryo. Others play key roles in neurological processes and in behaviour [10, 11] . As a consequence, perturbations in imprinted gene expression are an important cause of several growth and behavioural syndromes in humans including the Beckwith-Wiedemann, Amandine Henckel has worked, during her PhD, on the epigenetic regulation of genomic imprinting. She is currently a postdoctoral researcher at the Max Planck Institute in Freiburg, Germany, where she is interested in the histone H1 and its role in chromatin organisation. Philippe Arnaud is a research scientist in the 'Institut de Génétique Moléculaire', CNRS. His research interests are on the role of DNA methylation and histone modifications in the regulation of genomic imprinting in mammals.
Prader-Willi and Angelman syndromes [12] , as well as in cancer [13] .
Despite the major advances of the past 25 years, the picture of the biological functions in which imprinting plays a role is probably not completed yet and therefore the accurate identification of the whole set of imprinted genes present in mammalian genomes is crucially needed.
In this review, after a brief characterization of imprinted genes, we describe the new approaches that are currently used to identify novel imprinted genes with a strong emphasis on the potential of recently developed high throughout approaches.
MAIN FEATURES OF IMPRINTED GENES
Imprinted genes are distributed throughout the genome. Although some are isolated and others occur in pairs, the majority are organized in clusters that are up to one megabase in size and are structurally conserved between human and mouse. These imprinted domains contain both maternally and paternally expressed genes as well as non-imprinted genes and at least one non-coding RNA in most cases ( Figure 1 ).
The allele-specific expression of imprinted genes (and more broadly of imprinted loci) is regulated by epigenetic modifications of which DNA methylation is a major component. Notably, the discrete cisacting regions that orchestrate imprinted monoallelic expression (referred to as ICRs for imprinting control regions) all coincide with differentially methylated region (DMR) harbouring allelic DNA methylation inherited from the male or female gamete (the germline DMR) [14, 15] . Germline acquisition of DNA methylation at ICRs requires the DNA methyltransferase 3A (DNMT3A) [16] in cooperation with the DNA methyltransferase 3 Like (DNMT3L) [14, 17] . Once acquired, DNA methylation imprints are maintained in all the somatic lineages throughout development and adult life. These imprinting marks are 'read' in different ways to ensure appropriate parental allele-specific expression [12] . Schematically, differential DNA methylation of ICRs is thought to initiate a sequence of events that will lead to the coordinated allele-specific expression of entire clusters of imprinted genes. Importantly, for many imprinted genes these 'reading' mechanisms and the consequent expression of the imprinted genes are limited to specific tissues or developmental stages, despite the constitutive presence of the allelic DNA methylation imprint at the ICR (Figure 1 ). Beside germline DMRs at ICRs, imprinted domains can also contain DMRs at which parental allelespecific methylation is established after fertilization only. These so called 'somatic DMRs' are found at promoters of some imprinted genes and can be tissue-specific ( Figure 1 ).
IDENTIFICATION OF IMPRINTED GENES
Beside the data obtained using uniparental conceptuses, the existence of imprinted genes was further supported by genetic studies on mouse embryos that were uniparentally disomic for individual chromosomes, or for chromosomal regions (i.e. mice that have inherited two maternal copies and no paternal copy, or vice versa, of a chromosome or portion of a chromosome). Mice characterized by uniparental disomy (UPD) of different chromosomal regions to cover almost the entire mouse genome were used to carry out a phenotypic screen for imprinting effects [18] . By identifying a number of regions in which UPD caused a broad range of phenotypic abnormalities, including abnormal growth and embryonic lethality, this approach allowed the delineation of genomic regions that are likely to contain imprinted genes. The results of this screen constitute the 'backbone' of the current imprinting map (http://www .har.mrc.ac.uk/research/genomic_imprinting/) [19] and many of the imprinted genes identified so far map to the 'imprinted' regions that have been delineated by using UPD mice. However, not all imprinted genes are necessarily in these regions. For instance, regions containing imprinted genes, the deregulation of which leads to a 'subtle' developmental effect, might not be revealed by this kind of phenotypic screen or their identification as imprinted regions can be made difficult by earlier lethality or phenotypes on the same chromosome. The evaluation of the full biological function of imprinted genes requires thus genome-wide approaches that enable the identification of imprinted genes independently of their genomic localization. To this end, dedicated screens that are based on three main specific features of imprinted loci (i.e. DNA sequence characteristics, imprinted expression and epigenetic signature) have been developed ( Table 1 ).
IMPRINTED GENE PREDICTION THROUGH DNA SEQUENCE CHARACTERISTICS
The identification of an important number of imprinted genes offers opportunities for the computational identification of candidate imprinted genes. Computational approaches are based on the identification of specific sequence characteristics that are shared by imprinted genes [20] [21] [22] [23] [24] . Specifically, human imprinted regions significantly lack short interspersed transposable elements (SINEs) in comparison to non-imprinted loci [20, 21] . The first large-scale prediction of imprinted genes based on DNA sequence characteristics alone was performed by Luedi et al. [25] . They conducted a comparative analysis of DNA sequence features in 44 known imprinted genes and 530 genes presumed, but not experimentally determined, to be nonimprinted in the mouse genome. This analysis included statistics on the distribution of several families of repetitive elements, transcription factor binding sites and CpG islands. Among the most 
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ChIP-chip, ChIP-seq Figure 1 : Canonical view of an imprinted domain. Schematic representation of a putative imprinted domain that comprises imprinted (maternally-and paternally-expressed) and non-imprinted coding genes as well as an imprinted non-coding RNA (dotted line). Imprinted expression is controlled by a maternally methylated (filled lollipops) germline DMR/ICR (hatched oval) and further relies, for a single transcript, on a tissue-specific paternally methylated region (somatic DMR). The epigenetic signature at the ICR is maintained during all somatic development, although imprinted expression can vary from one tissue and/or developmental stage to another (compare tissue A and B).
significant characteristics identified, the authors confirmed that low concentration of SINEs is a significant feature of imprinted regions and determined that their orientation relative to the imprinted gene has a high discriminatory value. In addition, the presence within introns of endogenous retrovirus elements (ERVs) and long interspersed element (LINE) L1s is also likely to be important to predict the imprinting status of a gene. Subsequently, these 'predictive' features were used to train a classifier to predict the imprinted or non-imprinted status of a gene and from which parental allele a candidate imprinted gene should be expressed. Application of this classifier to a total of 23 788 annotated autosomal genes resulted in the identification of 600 (2.5%) candidate imprinted genes, of which 384 (64%) were predicted to be maternally expressed [25] . A similar, but more conservative and selective approach based on the combined use of four classifiers was then used to analyse the human genome [26] . This strategy allowed the prediction of 156 imprinted genes (0.75%) out of the 20 770 annotated autosomal genes, and 88 (56%) of them were predicted to be expressed on the maternal allele [26] . The difference in the percentage of predicted imprinted genes in the mouse and human genomes (2.5 and 0.75%, respectively) can be explained by the use of a more stringent approach, but may also highlight the fact that the human genome contains fewer imprinted genes than the mouse genome [26] . Furthermore, the number of predicted imprinted genes in both genomes was probably underestimated as these studies were largely restricted to proteincoding genes. Finally, among the 156 candidates in the human genome, only disk-large associated protein 2 (DLGAP2) and potassium channel, subfamily K, member 9 (KCNK9), which were selected due to their high probability to be imprinted, were experimentally demonstrated to be imprinted and to be expressed from the predicted parental allele [26] . Interestingly, Kcnk9 was previously shown to be imprinted with maternal and brain-specific expression also in the mouse [27] . In this study, 16 promising candidate imprinted genes were selected among the 600 predicted by Luedi et al. [25] in the mouse genome and their imprinted status was tested in E11.5 mouse embryos. With the exception of Kcnk9, the other 15 genes did not show evidence of imprinted expression at this developmental stage [27] .
Beside prediction based on LINE and SINE density, an original study has identified novel imprinted genes (e.g. Mcts2) through a hypothesis-driven search for intronic X-chromosome derived retro-elements [24] .
The analysis of all these studies indicates that the overall success rate in the identification of new imprinted genes based on sequence features alone remains low, highlighting that such approach has to be considered promising but still in need of improvements. Furthermore, such bioinformatics-based screens cannot substitute, but rather only assist, the direct experimental approach/validation.
SCREENS BASED ON GENE EXPRESSION ANALYSIS
Screens dedicated to unravelling parental allelic imbalance in gene expression appear especially suitable to identify imprinted loci. However, the design of such expression screens needs to fulfil several important requirements: (i) ideally the cDNA source should allow the discrimination of the maternal and paternal alleles; (ii) the cDNA source should represent both protein-coding and non-coding genes (non-coding RNAs) as the expression of both can be regulated by imprinting; (iii) only genes that are imprinted in that tissue and/or at the developmental stage analysed will be identified; (iv) genes identified by these screens need to be distinguished from genes which show random mono-allelic expression [28] [29] [30] .
The first successful expression screens were based on subtractive hybridization and differential display techniques performed using cDNA from uniparental (i.e. gynogenetic and androgenetic) embryos or embryonic fibroblast cell lines [31] [32] [33] . The subsequent development of high throughput microarray techniques allowed screening of the expression of thousands of genes at the same time. Specifically, a large-scale microarray comprising 27 663 full-length mouse cDNAs was utilized to identify imprinted genes by comparing gene expression levels in whole 9.5 dpc gynogenetic and androgenetic mouse embryos. This analysis identified more than 2100 imprinted candidate transcripts (1403 maternally-and 698 paternally-expressed, respectively), including 56 non-coding RNAs [9] . In a more recent study, gene expression levels in 9.5 dpc-old gynogenetic and control embryos were compared using the Affymetrix GeneChip probe array, which contains more than 45 000 genes and ESTs. 'Only' 39 candidate transcripts (including 18 genes already known to be imprinted), which were paternally expressed, were identified [34] . However, when these results were experimentally validated, only very few of the candidate transcripts were successfully confirmed as imprinted while the majority showed no imprinted expression [8, 32, 34, 35] . Combined, these observations are consistent with the idea that the disruption of imprinted gene expression in parthenogenetic and andrenogenetic embryos (and the ensuing developmental defects) might affect also the expression of many non-imprinted genes, which would be detected as false imprinted genes when using uniparental material in expression screens [32, 34, 35] . In addition, uniparental mouse embryos are arrested early in post-implantation development, thus making not possible the identification of imprinted genes that are expressed at later stages during development and/or in tissues which are not yet present or are not functional in such embryos at the moment of death.
Mouse strains that carry specific UPDs or duplications of 'imprinted' chromosomal regions [18, 36] can, at least partially, overcome these limitations. Some of these strains are indeed viable until birth, so that differential gene expression profiles can be investigated in different tissues and compared with the profiles obtained in wild type animals using the microarray technology [37] . Such an approach has successfully identified imprinted genes, of which some were imprinted in a tissue-specific manner [38] [39] [40] [41] . For instance, Schulz et al. [41] conducted microarray experiments using cDNA derived from different tissues of UPD mice and successfully identified three new maternally expressed genes in the placenta and four novel, brain-specific, paternally expressed transcripts. However, the limitations of expression screens based on UPD mice are obvious. Indeed, the investigation for new imprinted candidates is restricted to phenotypically-defined 'imprinted' chromosomal regions [18, 36] . In addition, as in uniparental embryos, the imprinted defects observed in these embryos may distort the expression pattern of non-imprinted genes, generating falsepositive imprinted genes.
An alternative approach is the use of informative single nucleotide polymorphic (SNP) variants that enable not only to establish the parental origin of expression of a given gene, but also to screen physiologically normal 'material'. These can be done in the mouse by reciprocal crossing of different mouse strains. In humans, in order to decipher the origin of complex diseases, haplotype map databases have been built by the international HapMAp consortium (http://hapmap.ncbi.nlm.nih.gov/) and the '1000 genomes' project (http://browser.1000genomes .org/index.html). The identified informative human SNPs, which are available at the dsSNP database (http://www.ncbi.nlm.nih.gov/projects/ SNP/), can be used in transcription screens to determine the allelic expression of a specific gene or set of genes. Several studies used a SNP-specific microarray approach to investigate allelic-specific expression in human tissues [42] and cell lines [28, 29, 43] . While not necessarily dedicated to the prediction of new imprinted genes, these studies did confirm the differential allelic expression of known imprinted genes and identified several 'high-confidence' new imprinted transcripts. However, the main outcome of these studies is that allelic expression bias, irrespectively of the parental origin of the alleles, is a widespread phenomenon in the human genome [28] , possibly affecting up to 20% of genes [30] . In order to identify new imprinted genes, Pollard et al. [44] designed an approach that allowed discriminating 'true' candidate imprinted genes from those that present random mono-allelic expression. In this study allelic expression was investigated using SNP-specific microarrays in lymphoblastoid cell lines derived from 67 unrelated individuals. Among the genes, which showed differential allelic expression, 'true' candidate imprinted genes were identified through the over-or under-expression of the SNP-associated-allele in comparison to the other allele in different heterozygous individuals. Accordingly, out of the 2625 human genes analysed 61 candidate imprinted genes were identified. Among the 15 genes (out of the 61 identified) experimentally tested for imprinting, seven showed strong evidence of, which was however not formally proven, being imprinted. Given that this screen covered 10% of the protein-coding genes in humans (but not the non-coding RNAs), we should expect no more than a few hundred imprinted genes in lymphoblastoid cells [44] . Although forthcoming microarrays will offer a more extensive coverage, such an approach has several limitations. The analysis is conducted on custom-selected, and necessarily limited, genomic regions and they require an a priori knowledge of SNP position and transcript sequences. In addition, microarrays analysis cannot give a reliable quantitative ratio of the expression of a given gene at the two parental alleles, thus not facilitating the identification of imprinted genes that display an allelic parental bias (rather than an 'all-or-none') in expression.
The recent development of computer-assisted deep-sequencing approaches, the next-generation sequencing technologies, provides a powerful and promising alternative to microarray-based analyses. Particularly interesting for the identification of new imprinted genes is the RNA-sequencing (RNA-seq) approach [45] because it enables quantitative measurements of allelic bias in whole transcriptomes when applied to polymorphic cDNA sources. Wang et al. [46] sequenced the entire transcriptome of neonatal brain samples from mice generated from reciprocal crossing between different strains. They identified 26 candidate imprinted genes, including 12 novel genes of which only three were finally predicted to be imprinted. A similar approach was used by Babak et al. [47] to build a map of imprinted genes in 9.5 dpc mouse embryos. The design for the cDNA synthesis from strand-specific total RNA allowed including intronic regions and non-polyadenylated transcripts. This approach identified 80% of the already known imprinted genes and further confirmed the existence of six novel imprinted genes. In addition, this map highlighted the incomplete characterization of known imprinted loci by revealing novel imprinted transcripts in these regions (including non-coding RNAs) [47] .
Besides transcriptome analysis, mono-allelic gene expression can be assessed by investigating allele-specific binding of transcription factors. In an innovative approach, Maynard et al. [48] investigated allele-specific binding of RNA polymerase II (RNAP) in human lung fibroblasts. They designed a ChIP-SNP approach in which regions precipitated with an anti-RNAP antibody were analysed using a SNP genotyping microarray. By this means, in addition to identifying already known imprinted genes they demonstrated that a microRNA cluster adjacent to MEG3 and known to be imprinted in the sheep and mouse is also imprinted in humans [48] .
SCREENS BASED ON EPIGENETIC FEATURES
Screens based on the detection of differences in the epigenetic marks (i.e. DNA methylation, histone modifications) that are present at the maternal and paternal allele of a given gene also provide a relevant strategy to identify novel imprinted loci. Allelic epigenetic differences are evident at ICRs, key regions for the regulation of imprinting (Figure 1 ). ICRs are marked by DNA methylation acquired on either the maternal or the paternal allele in the female or male germ line (constituting a germline DMR) [12] . In addition to DNA methylation, ICRs are also marked by differential histone modifications in somatic cells (see below) [49] [50] [51] [52] . The main advantage of screens focused on the identification of germline DMRs/ICRs is that they can be carried out in any cell type because their epigenetic marks are maintained throughout development and adult life, regardless of the expression status of the imprinted genes (Figure 1 ). On the other hand, ICRs are discrete elements that often control entire imprinted clusters which cover hundreds to thousands of kilobases and can contain more than 10 genes (Figure 1) . Therefore, such screens are more likely to identify chromosomal regions with several imprinted genes rather than individual imprinted genes. The concomitant identification of differentially methylated somatic regions (somatic DMRs) at promoters could more readily reveal individual imprinted genes. However, these features are more an exception than a generality as most of the promoters of imprinted genes identified so far do not show allelic differences in DNA methylation ( Figure 1) .
As in transcriptomic analyses, the last years witnessed a tremendous technological progress that facilitates genome-wide profiling of epigenetic features in an unbiased way. Methylated DNA isolated by precipitation with anti-5mC antibodies (MeDIP assay) or Methyl-CpG Binding proteins (MIRA assay) can be further analysed through microarray hybridization or deep sequencing methods [53] [54] [55] . Another promising approach is bisulphitesequencing (BS-seq) in which methylationdependent bisulphite conversion of DNA (to differentiate between methylated and unmethylated cytosines) is combined with high-throughput sequencing to quantitatively map DNA methylation at singlebase resolution in a whole genome [56] . Similarly, genome-wide profiling of histone modifications is obtained by specific chromatin immunoprecipitation followed by tiling array hybridization (ChIP-chip) or deep sequencing (ChIP-seq) [57] .
As described below, these technical breakthroughs offer powerful means to undertake a systematic study in order to identify novel imprinted loci and should provide major insights in the coming years.
Screens based on differential methylation
The first successful screens, such as restriction landmark genomic scanning (RLGS) [58] and methylation-sensitive representational difference analysis (Me-RDA) [59] , applied an approach based on the use of methylation sensitive restriction enzymes [60] [61] [62] . This strategy was then used to map methylated CpG islands in the human genome in order to identify new imprinted genes [63, 64] . Indeed, most, although not all, ICRs share also CpG island features. The rationale for this strategy is based on the observation that the majority of CpG islands present in the mouse and human genomes are normally unmethylated, thus one can expect that a relevant proportion of the methylated ones would be located at imprinted loci.
A major drawback of this approach comes from the initial digestion with a site-specific restriction enzyme that drastically reduces the coverage of the analysis.
Genome-wide maps of methylated cytosines (i.e. methylomes) obtained by unbiased approaches should enable the systematic identification of DMRs. Of particular interest is the recent demonstration that the BS-Seq approach is applicable to the complex human [65] and mouse [66] genomes. Further developments in which such approaches will be combined with SNP data would be extremely useful to efficiently identify new candidate DMRs associated with imprinted loci. Alternatively, genome-wide DNA methylation profiling can also be used to compare the normal genome to those known to present with methylation imprint defects. This method was recently successfully applied in a study [67] in which genome-wide CpG methylation analysis was carried out using blood samples from a patient with multiple imprinting defects and normal controls. Following bisulphite treatment, DNA was hybridized to a commercially available array developed to assay CpG methylation in more than 14 000 genes. In addition to confirming in this patient the hypomethylation of known 'imprinted' DMRs, this study identified new candidate DMRs. One of these regions was associated with RB1 which was then demonstrated to be imprinted in humans [67] . sites (a protein known to have regulatory function in imprinting) identify imprinted regions in human T cells and immortalized lymphoblast cell lines.
CONCLUSIONS
The characterization of more than 110 of imprinted genes during the last 20 years has greatly expanded our understanding of the regulation and function of genomic imprinting. For instance, beside a role in growth and development, their involvement in neurological processes and in behaviour also has been highlighted [11] . Nonetheless, the current list of imprinted genes, and the full biological meaning of genomic imprinting, is probably incomplete.
Although estimates of the total number of imprinted transcripts rose up to 2100 [8] , combined studies suggest that their actual number should not exceed few hundreds. For instance, transcriptome approaches using mouse neonatal brain samples, one of the main 'target' tissues for imprinting with placenta [7] , identified only three novel proteincoding imprinted genes [46] . In addition, another comprehensive transcriptomic analysis conducted on whole 9.5 dpc mouse embryos further supported the idea that most of the yet-uncharacterized imprinted genes are transcripts and non-coding RNAs that are localized mainly in already known imprinted domains [47] .
An important issue is also to establish to which extend imprinting is present in the human genome. Although the imprinting status of some genes identified in mouse is conserved in the human orthologues, both mouse-and human-specific imprinting is documented [6, 7] . This means that although the data gathered in the mouse can be used as a frame to select which novel imprinted genes to test in humans, genome-wide screens completely focused on the human genome are also required in order to precisely identify all the imprinted genes in humans.
A systematic investigation of novel imprinted gene candidates in the mouse and human genomes is now virtually feasible. The remarkable progress made in genome-wide profiling of histone modifications and DNA methylation, combined with SNP information, provides powerful tools to screen genomic regions for chromatin signatures known to constitutively mark imprinted regions. In addition, the establishment of comprehensive epigenetic maps of mutants of key regulators of imprinting will be an extremely promising approach for a systematic identification of imprinted genes. For instance, the progeny of mouse females deficient for DNMT3L, in which we can expect methylation defects only in imprinted genes [14, 17] , as well as human complete hydatidiforme moles or ovarian teratomas, which contain only one parental DNA set, are relevant material to establish such maps. In parallel, transcriptome sequencing offers an extremely informative and powerful approach to carry out systematic surveys on imprinted gene expression in various tissues.
A further obvious development relies on combining these different approaches. Computationalassisted crossing of databases obtained through epigenome-and transcriptome-wide analyses should offer the unique opportunity of establishing the full list of 'high-confidence' candidate imprinted genes. Nonetheless, it is important to keep in mind that any identified candidate necessarily requires to be experimentally validated as an imprinted gene through classical approaches.
